IceCure Medical (ICCM) Equity Average (2021 - 2025)
IceCure Medical (ICCM) has disclosed Equity Average for 4 consecutive years, with $9.5 million as the latest value for Q4 2024.
- On a quarterly basis, Equity Average fell 49.28% to $9.5 million in Q4 2024 year-over-year; TTM through Dec 2024 was $9.5 million, a 49.28% decrease, with the full-year FY2024 number at $9.5 million, down 49.28% from a year prior.
- Equity Average was $9.5 million for Q4 2024 at IceCure Medical, down from $18.8 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $26.2 million in Q4 2022 to a low of $9.5 million in Q4 2024.
- A 4-year average of $17.7 million and a median of $17.5 million in 2021 define the central range for Equity Average.
- Peak YoY movement for Equity Average: soared 60.65% in 2022, then crashed 49.28% in 2024.
- IceCure Medical's Equity Average stood at $16.3 million in 2021, then surged by 60.65% to $26.2 million in 2022, then fell by 28.25% to $18.8 million in 2023, then tumbled by 49.28% to $9.5 million in 2024.
- Per Business Quant, the three most recent readings for ICCM's Equity Average are $9.5 million (Q4 2024), $18.8 million (Q4 2023), and $26.2 million (Q4 2022).